Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Time Frame
Facet Toggle
Oct
9
2019
12:00—1:30 PM
October 01, 2019
Public health programs such antiretroviral therapy (ART) for HIV are likely to have positive spillover benefits to community members beyond the targeted beneficiaries that could be many times larger than the direct benefits. Join CGD for a brownbag seminar to discuss Dr. Zoë McLaren’s rec...
Aug
10
2017
12:30—2:00 PM
July 31, 2017
The 2014-2015 Ebola epidemic broke out and affected thousands of people at a time when there were no medicines approved to treat or prevent Ebola. Poor infrastructure, capacity gaps, widespread mistrust, and disagreements over the design and ethical nature of any clinical trials complicated efforts ...
Jun
28
2016
12:30—2:00 PM
June 17, 2016
Join us for a seminar with economist Markus Haacker, who will discuss the motivations behind and findings from his forthcoming book, The Economics of the Global Response to HIV/AIDS. As in the book, Haacker will review the global impact of and response to HIV/AIDS to date. He will also address ...
Feb
23
2016
3:30—4:30 PM
February 19, 2016
The Institute for Disease Modeling conducts quantitative research aimed at disease eradication through the application of tools such as statistical and individual-based modeling. This talk will provide an overview of the Institute, and then focus on several vignettes that highlight how modelin...
Oct
8
2015
2:30—4:00 PM
October 06, 2015
Global financial resources for health have substantially increased over the period of the MDGs but are now steady or declining. Domestic resources in low- and middle-income countries may not be able to keep up with demand for treatment needs, let alone other prevention services. In this context, the...
Sep
29
2015
12:30—2:00 PM
September 22, 2015
The world recently reached a milestone in the fight against HIV/AIDS: 15 million people around the globe now have access to life-saving antiretroviral therapy (ART). In 2001, only 1 million people had such access. This has resulted in tremendous gains in population health and life expectancy for HIV...
Jun
4
2015
12:30—2:00 PM
May 26, 2015
Determining which health interventions represent good value for money and are therefore good investments is an ongoing challenge for policymakers. A common approach to making these decisions has involved the use of thresholds based on per capita GDP. Specifically, many countries follow the World Hea...
Jan
13
2015
9:30—11:30 AM
January 05, 2015
The Center for Global Development is pleased to host a discussion on Liberia after Ebola, featuring Senator Jeff Flake and Liberian Minster of Public Works, Gyude Moore.
The 2014 Ebola outbreak in West Africa continues to have an extraordinary human cost. But as the outbreak in Liberia appears ...
Jun
17
2014
1:00—2:30 PM
June 11, 2014
A health policy decision is only as good as the information available to the decision maker. As countries strive to achieve Universal Health Coverage and funding from local governments and global donors is scrutinized, there is an acute need for more and better economic evaluation to inform governme...
Apr
28
2014
4:00—6:00 PM
April 24, 2014
The World Bank presents the Philip Musgrove Memorial Lecture, featuring CGD Senior Fellow Mead over. Despite tremendous medical progress, the struggle to control the AIDS epidemic is not yet won. Biomedical marvels notwithstanding, individual behavior is arguably the most important determinant of HI...